Relationship between Serum Levels of Selenium and Thyroid Cancer: A Systematic Review and Meta-Analysis

References

• Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–34. doi:10.1016/S2213-8587(21)00027-9
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020;8(6):468–70. doi:10.1016/S2213-8587(20)30115-7
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–53. doi:10.1038/nrendo.2016.110
   PubMed Web of Science ®Google Scholar
• Zhang L, et al. Identification of risk factors for thyroid cancer in urumqi, china. Int J Clin Exp Path. 2017;10(1):717–23.
   Web of Science ®Google Scholar
• Margalioth EJ, Schenker JG, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer. 1983;52(5):868–72. doi:10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• Zaichick V, Tsyb AF, Vtyurin BM. Trace elements and thyroid cancer. Analyst. 1995;120(3):817–21. doi:10.1039/an9952000817
   PubMed Web of Science ®Google Scholar
• Cayir A, Doneray H, Kurt N, Orbak Z, Kaya A, Turan MI, Yildirim A. Thyroid functions and trace elements in pediatric patients with exogenous obesity. Biol Trace Elem Res. 2014;157(2):95–100. doi:10.1007/s12011-013-9880-8
   PubMed Web of Science ®Google Scholar
• Triggiani V, Tafaro E, Giagulli VA, Sabbà C, Resta F, Licchelli B, Guastamacchia E. Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocr Metab Immune Disord Drug Targets. 2009;9(3):277–94. doi:10.2174/187153009789044392
   PubMedGoogle Scholar
• Arthur JR, Beckett GJ. Thyroid function. Br Med Bull. 1999;55(3):658–68. doi:10.1258/0007142991902538
   PubMed Web of Science ®Google Scholar
• Köhrle J. Selenium and the control of thyroid hormone metabolism. Thyroid. 2005;15(8):841–53. doi:10.1089/thy.2005.15.841
   PubMed Web of Science ®Google Scholar
• Berry MJ, Banu L, Larsen PR. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature. 1991;349(6308):438–40. doi:10.1038/349438a0
   PubMed Web of Science ®Google Scholar
• Kohrle J, et al. Selenium in biology: Facts and medical perspectives. Biol Chem. 2000;381(9–10):849–64.
   PubMed Web of Science ®Google Scholar
• Croteau W, Davey JC, Galton VA, St Germain DL. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest. 1996;98(2):405–17. doi:10.1172/JCI118806
   PubMed Web of Science ®Google Scholar
• Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64(4):527–42. doi:10.1079/pns2005467
   PubMed Web of Science ®Google Scholar
• Köhrle J, Jakob F, Contempré B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev. 2005;26(7):944–84. doi:10.1210/er.2001-0034
   PubMed Web of Science ®Google Scholar
• Chiu-Ugalde J, Wirth EK, Klein MO, Sapin R, Fradejas-Villar N, Renko K, Schomburg L, Köhrle J, Schweizer U. Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal. 2012;17(6):902–13. doi:10.1089/ars.2011.4055
   PubMed Web of Science ®Google Scholar
• Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. 2015;48(3):756–75. doi:10.1007/s12020-014-0477-6
   PubMed Web of Science ®Google Scholar
• Burk RF, Hill KE. Regulation of selenium metabolism and transport. Annu Rev Nutr. 2015;35:109–34. doi:10.1146/annurev-nutr-071714-034250
   PubMed Web of Science ®Google Scholar
• Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr. 2009;89(6):2025s–39s. doi:10.3945/ajcn.2009.27230F
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Danielsen M, Wang H. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid. 2013;23(9):1079–86. doi:10.1089/thy.2012.0548
   PubMed Web of Science ®Google Scholar
• Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol. 1989;18(1):45–9. doi:10.1093/ije/18.1.45
   PubMed Web of Science ®Google Scholar
• Kucharzewski M, Braziewicz J, Majewska U, Góźdź S. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res. 2002;88(1):25–30. doi:10.1385/BTER:88:1:25
   PubMed Web of Science ®Google Scholar
• Moncayo R, Kroiss A, Oberwinkler M, Karakolcu F, Starzinger M, Kapelari K, Talasz H, Moncayo H. The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord. 2008;8:2. doi:10.1186/1472-6823-8-2
   PubMedGoogle Scholar
• Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Elem Res. 2017;175(1):57–64. doi:10.1007/s12011-016-0768-2
   PubMed Web of Science ®Google Scholar
• Stojsavljević A, Rovčanin B, Jagodić J, Krstić Đ, Paunović I, Gavrović-Jankulović M, Manojlović D. Alteration of trace elements in multinodular goiter, thyroid adenoma, and thyroid cancer. Biol Trace Elem Res. 2021;199(11):4055–65. doi:10.1007/s12011-020-02542-9
   PubMed Web of Science ®Google Scholar
• Przybylik-Mazurek E, Zagrodzki P, Kuźniarz-Rymarz S, Hubalewska-Dydejczyk A. Thyroid disorders-assessments of trace elements, clinical, and laboratory parameters. Biol Trace Elem Res. 2011;141(1–3):65–75. doi:10.1007/s12011-010-8719-9
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii–x,1–173. doi:10.3310/hta7270
   PubMedGoogle Scholar
• Shen F, Cai W-S, Li J-L, Feng Z, Cao J, Xu B. The association between serum levels of selenium, copper, and magnesium with thyroid cancer: a meta-analysis. Biol Trace Elem Res. 2015;167(2):225–35. doi:10.1007/s12011-015-0304-9
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. doi:10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Lee JH, Chai YJ, Yi KH. Effect of cigarette smoking on thyroid cancer: meta-analysis. Endocrinol Metab (Seoul). 2021;36(3):590–8. doi:10.3803/EnM.2021.954
   PubMedGoogle Scholar
• Köhrle J. The deiodinase family: selenoenzymes regulating thyroid hormone availability and action. Cell Mol Life Sci. 2000;57(13–14):1853–63.
   PubMed Web of Science ®Google Scholar
• Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):815–27. doi:10.1016/j.beem.2009.08.002
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–22. doi:10.1001/jamaoto.2014.1
   PubMed Web of Science ®Google Scholar
• Glattre E, Nygård JF, Aaseth J. Selenium and cancer prevention: observations and complexity. J Trace Elem Med Biol. 2012;26(2–3):168–9. doi:10.1016/j.jtemb.2012.04.021
   PubMed Web of Science ®Google Scholar
• Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015;39(4):511–8. doi:10.1016/j.canep.2015.04.015
   PubMed Web of Science ®Google Scholar
• Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212. doi:10.1155/2013/965212
   PubMedGoogle Scholar
• Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC. A prospective study of selenium status and breast cancer risk. Jama. 1990;264(9):1128–31. doi:10.1001/jama.1990.03450090064026
   PubMed Web of Science ®Google Scholar
• Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci. 2009;66(15):2457–78. doi:10.1007/s00018-009-0032-4
   PubMed Web of Science ®Google Scholar
• Gandin V, Khalkar P, Braude J, Fernandes AP. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radic Biol Med. 2018;127:80–97. doi:10.1016/j.freeradbiomed.2018.05.001
   PubMed Web of Science ®Google Scholar
• Bösl MR, Takaku K, Oshima M, Nishimura S, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci USA. 1997;94(11):5531–4. doi:10.1073/pnas.94.11.5531
   PubMed Web of Science ®Google Scholar
• Kipp AP. Selenium in colorectal and differentiated thyroid cancer. Hormones (Athens). 2020;19(1):41–6. doi:10.1007/s42000-019-00118-4
   PubMedGoogle Scholar
• Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab. 2010;95(12):5180–8. doi:10.1210/jc.2010-0191
   PubMed Web of Science ®Google Scholar
• Banning A, Kipp A, Schmitmeier S, Löwinger M, Florian S, Krehl S, Thalmann S, Thierbach R, Steinberg P, Brigelius-Flohé R, et al. Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice. Cancer Res. 2008;68(23):9746–53. doi:10.1158/0008-5472.CAN-08-1321
   PubMed Web of Science ®Google Scholar
• Roger PP, van Staveren WCG, Coulonval K, Dumont JE, Maenhaut C. Signal transduction in the human thyrocyte and its perversion in thyroid tumors. Mol Cell Endocrinol. 2010;321(1):3–19. doi:10.1016/j.mce.2009.11.015
   PubMed Web of Science ®Google Scholar
• Myung S-K, Lee CW, Lee J, Kim J, Kim HS. Risk factors for thyroid cancer: a hospital-based case-control study in Korean Adults. Cancer Res Treat. 2017;49(1):70–8. doi:10.4143/crt.2015.310
   PubMed Web of Science ®Google Scholar
• Smith ML, Lancia JK, Mercer TI, Ip C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res. 2004;24(3a):1401–8.
   PubMed Web of Science ®Google Scholar
• Aichler M, Algül H, Behne D, Hölzlwimmer G, Michalke B, Quintanilla-Martinez L, Schmidt J, Schmid RM, Brielmeier M. Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-alpha p53+/mice. Carcinogenesis. 2007;28(9):2002–7. doi:10.1093/carcin/bgm165
   PubMed Web of Science ®Google Scholar
• Fischer JL, Mihelc EM, Pollok KE, Smith ML. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther. 2007;6(1):355–61. doi:10.1158/1535-7163.MCT-06-0472
   PubMed Web of Science ®Google Scholar
• Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci USA. 2002;99(20):12985–90. doi:10.1073/pnas.202485699
   PubMed Web of Science ®Google Scholar
• Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA. 1999;96(2):424–8. doi:10.1073/pnas.96.2.424
   PubMed Web of Science ®Google Scholar
• Janovsky CCPS, Bittencourt MS, Novais MAPd, Maciel RMB, Biscolla RPM, Zucchi P. Thyroid cancer burden and economic impact on the Brazilian public health system. Arch Endocrinol Metab. 2018;62(5):537–44. doi:10.20945/2359-3997000000074
   PubMed Web of Science ®Google Scholar
• Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, Xu P, Yang S, Zhai Z, Zhou L, et al. Global Burden of Thyroid Cancer From 1990 to 2017. JAMA Netw Open. 2020;3(6):e208759. doi:10.1001/jamanetworkopen.2020.8759
   PubMed Web of Science ®Google Scholar